Home Healthcare Market by Product (Therapeutic, Testing, Screening, Monitoring, Mobility Care), Service (Nursing, Infusion Therapy, Rehabilitation, Palliative Care), Indication (Cancer, Diabetes, CVD, Respiratory, Wound Care) - Global Forecast to 2030

1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.3 MARKET SCOPE 29 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 29 1.3.2 INCLUSIONS AND EXCLUSIONS 30 1.3.3 YEARS CONSIDERED 30 1.4 CURRENCY CONSIDERED 30 1.5 STAKEHOLDERS 31 1.6 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DATA 32 2.1.1 SECONDARY DATA 32 2.1.1.1 Key data from secondary sources 33 2.1.2 PRIMARY DATA 34 2.1.2.1 Primary sources 34 2.1.2.2 Key industry insights 35 2.1.2.3 Key data from primary sources 35 2.1.2.4 Breakdown of primary interviews 36 2.2 MARKET SIZE ESTIMATION 36 2.2.1 BOTTOM-UP APPROACH 37 2.2.1.1 Company revenue estimation approach 37 2.2.1.2 Presentations of companies and primary interviews 37 2.2.1.3 Primary interviews 38 2.2.1.4 Growth forecast 38 2.2.1.5 CAGR projections 38 2.2.2 TOP-DOWN APPROACH 38 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39 2.4 RESEARCH ASSUMPTIONS 40 2.4.1 PARAMETRIC ASSUMPTIONS 40 2.4.2 GROWTH RATE ASSUMPTIONS 41 2.5 RESEARCH LIMITATIONS 42 2.6 RISK ANALYSIS 42 3 EXECUTIVE SUMMARY 43   4 PREMIUM INSIGHTS 47 4.1 HOME HEALTHCARE MARKET OVERVIEW 47 4.2 GEOGRAPHIC GROWTH OPPORTUNITIES 48 4.3 HOME HEALTHCARE MARKET: GEOGRAPHIC MIX 49 4.4 HOME HEALTHCARE MARKET: DEVELOPED VS. DEVELOPING MARKETS 50 5 MARKET OVERVIEW 51 5.1 INTRODUCTION 51 5.2 MARKET DYNAMICS 51 5.2.1 DRIVERS 52 5.2.1.1 Growing elderly population and rising incidence of chronic diseases 52 5.2.1.2 Rapid technological advancements 53 5.2.1.3 Need for cost-effective healthcare delivery 54 5.2.1.4 Increased preference for personalized care 54 5.2.2 RESTRAINTS 55 5.2.2.1 Changing reimbursement policies 55 5.2.2.2 Limited insurance coverage 56 5.2.2.3 Patient safety concerns 56 5.2.3 OPPORTUNITIES 57 5.2.3.1 Rising focus on telehealth 57 5.2.3.2 Growing preference for home-based treatments 57 5.2.4 CHALLENGES 58 5.2.4.1 Shortage of home care workers 58 5.2.4.2 Lack of supporting infrastructure 58 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 59 5.4 PRICING ANALYSIS 59 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 60 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 60 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 61 5.5 VALUE CHAIN ANALYSIS 62 5.6 SUPPLY CHAIN ANALYSIS 63 5.7 ECOSYSTEM ANALYSIS 64 5.8 INVESTMENT AND FUNDING SCENARIO 65 5.9 TECHNOLOGY ANALYSIS 66 5.9.1 KEY TECHNOLOGIES 66 5.9.1.1 Vital sign monitoring devices 66 5.9.1.2 Wearable devices 66 5.9.2 COMPLEMENTARY TECHNOLOGIES 66 5.9.2.1 Health data platforms 66 5.9.2.2 Medication management system 67 5.9.3 ADJACENT TECHNOLOGIES 67 5.9.3.1 Augmented Reality and Virtual Reality (AR/VR) 67 5.10 PATENT ANALYSIS 67 5.11 TRADE ANALYSIS 70 5.11.1 IMPORT DATA (HS CODE 901890) 70 5.11.2 EXPORT DATA (HS CODE 901890) 70 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 71 5.13 REGULATORY LANDSCAPE 72 5.13.1 REGULATORY ANALYSIS 72 5.13.1.1 North America 72 5.13.1.1.1 US 72 5.13.1.1.2 Canada 73 5.13.1.2 Europe 74 5.13.1.3 Asia Pacific 75 5.13.1.3.1 Japan 75 5.13.1.3.2 China 76 5.13.1.3.3 India 77 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 5.14 PORTER’S FIVE FORCES ANALYSIS 80 5.14.1 BARGAINING POWER OF SUPPLIERS 81 5.14.2 BARGAINING POWER OF BUYERS 81 5.14.3 THREAT OF NEW ENTRANTS 81 5.14.4 THREAT OF SUBSTITUTES 82 5.14.5 INTENSITY OF COMPETITIVE RIVALRY 82 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 82 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 82 5.15.2 BUYING CRITERIA 83 5.16 IMPACT OF AI ON HOME HEALTHCARE MARKET 84 5.16.1 INTRODUCTION 84 5.16.2 MARKET POTENTIAL OF AI IN HOME HEALTHCARE MARKET 84 5.16.3 AI USE CASES 85 5.16.4 KEY COMPANIES IMPLEMENTING AI 86 5.16.5 FUTURE OF AI IN HOME HEALTHCARE MARKET 86 5.17 ADJACENT MARKETS FOR HOME HEALTHCARE MARKET 86 5.18 IMPACT OF US TARIFF REGULATION ON HOME HEALTHCARE MARKET 87 5.18.1 INTRODUCTION 87 5.18.2 KEY TARIFF RATES 87 5.18.3 PRICE IMPACT ANALYSIS 88 5.18.4 KEY IMPACT ON COUNTRY/REGION 88 5.18.4.1 North America 88 5.18.4.2 Europe 89 5.18.4.3 Asia Pacific 89 5.18.5 IMPACT ON END-USE INDUSTRIES 89 5.18.5.1 Home healthcare providers 89 6 HOME HEALTHCARE MARKET, BY PRODUCT 90 6.1 INTRODUCTION 91 6.2 THERAPEUTIC PRODUCTS 91 6.2.1 DIALYSIS EQUIPMENT 93 6.2.1.1 Favorable reimbursement scenario for home dialysis to favor growth 93 6.2.2 WOUND CARE PRODUCTS 94 6.2.2.1 Rising geriatric population and subsequent incidence of chronic diseases to amplify growth 94 6.2.3 IV EQUIPMENT 95 6.2.3.1 Technological advancements in IV therapy to contribute to growth 95 6.2.4 SLEEP APNEA THERAPEUTIC DEVICES 96 6.2.4.1 Increasing patient preference for home-based sleep tests to bolster growth 96 6.2.5 INSULIN DELIVERY DEVICES 97 6.2.5.1 High incidence of diabetes to favor growth 97 6.2.6 OXYGEN DELIVERY SYSTEMS 98 6.2.6.1 Growing trend of using oxygen therapy for respiratory disorders to propel market 98 6.2.7 INHALERS 99 6.2.7.1 High incidence of asthma to stimulate growth 99 6.2.8 NEBULIZERS 100 6.2.8.1 Faster relief and longer symptom control to accelerate growth 100 6.2.9 VENTILATORS 101 6.2.9.1 Growing use of positive airway pressure devices for sleep apnea therapy to drive market 101 6.2.10 OTHER THERAPEUTIC PRODUCTS 102 6.3 TESTING, SCREENING, AND MONITORING PRODUCTS 103 6.3.1 BLOOD GLUCOSE MONITORS 107 6.3.1.1 Increasing preference for self-diagnosis to contribute to growth 107 6.3.2 HEARING AIDS 108 6.3.2.1 High incidence of hearing impairment to augment growth 108 6.3.3 ACTIVITY MONITORS & WRISTBANDS 109 6.3.3.1 Increasing awareness about health and fitness to sustain growth 109 6.3.4 ECG/EKG DEVICES 109 6.3.4.1 High prevalence of cardiovascular diseases to support growth 109 6.3.5 TEMPERATURE MONITORING DEVICES 110 6.3.5.1 Rising use of digital thermometers for quick and accurate results to aid growth 110 6.3.6 HEART RATE MONITORS 111 6.3.6.1 Need for real-time monitoring to advance growth 111 6.3.7 PULSE OXIMETERS 112 6.3.7.1 Rising disease incidence and wide usage of pulse oximetry to promote growth 112 6.3.8 OVULATION & PREGNANCY TEST KITS 113 6.3.8.1 Privacy, convenience, accessibility, and quick results to facilitate growth 113 6.3.9 BLOOD PRESSURE MONITORS 114 6.3.9.1 Growing integration of pressure monitoring devices with digital health platforms to boost market 114 6.3.10 HIV TEST KITS 116 6.3.10.1 Increasing number of HIV-infected individuals globally to favor growth 116 6.3.11 FETAL MONITORING DEVICES 117 6.3.11.1 Increasing reliance on remote-based care to promote growth 117 6.3.12 HOLTER & EVENT MONITORS 118 6.3.12.1 Portability and storage attributes to aid growth 118 6.3.13 DRUG & ALCOHOL TEST KITS 119 6.3.13.1 Rise in drug abuse and alcohol consumption to support growth 119 6.3.14 COAGULATION MONITORING PRODUCTS 120 6.3.14.1 Rising incidence of deep vein thrombosis, pulmonary embolism, and hemophilia to foster growth 120 6.3.15 PEAK FLOW METERS 121 6.3.15.1 High portability and cost-efficiency to increase adoption 121 6.3.16 COLON CANCER TEST KITS 122 6.3.16.1 High incidence of colorectal cancer to drive market 122 6.3.17 EEG DEVICES 123 6.3.17.1 Wide patient population for epilepsy to fuel market 123 6.3.18 HOME SLEEP TESTING DEVICES 124 6.3.18.1 Need for specialized care at home to spur growth 124 6.3.19 CHOLESTEROL TESTING PRODUCTS 125 6.3.19.1 Rising obesity levels and cardiovascular incidence to augment growth 125 6.3.20 HOME HBA1C TEST KITS 126 6.3.20.1 Increasing recommendations for regular testing and favorable clinical outcomes to aid growth 126 6.4 MOBILITY CARE PRODUCTS 127 6.4.1 WHEELCHAIRS 129 6.4.1.1 Need for patient mobility with less pain and fatigue to fuel market 129 6.4.2 MOBILITY SCOOTERS 130 6.4.2.1 Increasing demand for mobility-assisted devices to facilitate growth 130 6.4.3 WALKERS & ROLLATORS 131 6.4.3.1 Rising prevalence for gait disorders, osteoarthritis, and other degenerative joint diseases to aid growth 131 6.4.4 CRUTCHES 132 6.4.4.1 Increasing use of crutches during post-operative recovery to boost market 132 6.4.5 CANES 133 6.4.5.1 Low cost, ease of use, and wide availability to contribute to growth 133 7 HOME HEALTHCARE MARKET, BY SERVICE 135 7.1 INTRODUCTION 136 7.2 SKILLED NURSING SERVICES 138 7.2.1 NEED FOR SPECIFIC PLAN OF CARE TO PROMOTE GROWTH 138 7.3 REHABILITATION THERAPY SERVICES 139 7.3.1 RISING DEMAND FOR IN-HOME CARE PERSONNEL TO STIMULATE GROWTH 139 7.4 HOSPICE & PALLIATIVE CARE SERVICES 140 7.4.1 INCREASING GERIATRIC POPULATION TO FACILITATE GROWTH 140 7.5 UNSKILLED CARE SERVICES 141 7.5.1 HIGHER AFFORDABILITY THAN HOSPITAL OR NURSING HOME SERVICES TO AID GROWTH 141 7.6 RESPIRATORY THERAPY SERVICES 142 7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET 142 7.7 INFUSION THERAPY SERVICES 143 7.7.1 SAFE AND EFFECTIVE ALTERNATIVE TO INPATIENT CARE TO ENCOURAGE GROWTH 143 7.8 PREGNANCY CARE SERVICES 144 7.8.1 NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE GROWTH 144 8 HOME HEALTHCARE MARKET, BY INDICATION 146 8.1 INTRODUCTION 147 8.2 CANCER 148 8.2.1 INCREASING PREFERENCE FOR AT-HOME TREATMENT TO EXPEDITE GROWTH 148 8.3 RESPIRATORY DISEASES 149 8.3.1 RISING INCIDENCE OF CHRONIC DISEASES TO SUSTAIN GROWTH 149 8.4 MOBILITY DISORDERS 150 8.4.1 GROWING GERIATRIC POPULATION TO BOOST MARKET 150 8.5 PREGNANCY 151 8.5.1 RISING FOCUS ON BETTER CARE AND MONITORING DURING PREGNANCY TO AID GROWTH 151 8.6 CARDIOVASCULAR DISEASES & HYPERTENSION 152 8.6.1 GROWING HEALTH AWARENESS TO DRIVE MARKET 152 8.7 WOUND CARE 153 8.7.1 INCREASING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO BOLSTER GROWTH 153 8.8 DIABETES 154 8.8.1 SHIFT IN CONSUMER PREFERENCE FROM TRADITIONAL TO MULTIFUNCTIONAL BLOOD GLUCOSE METERS TO SPUR GROWTH 154 8.9 HEARING DISORDERS 155 8.9.1 WORLDWIDE INCREASE IN HEARING DISABILITIES TO FOSTER GROWTH 155 8.10 OTHER INDICATIONS 156 9 HOME HEALTHCARE MARKET, BY REGION 158 9.1 INTRODUCTION 159 9.2 NORTH AMERICA 160 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 161 9.2.2 US 166 9.2.2.1 Significant demographic change to contribute to growth 166 9.2.3 CANADA 171 9.2.3.1 Growing elderly population to drive market 171 9.3 EUROPE 176 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 177 9.3.2 GERMANY 182 9.3.2.1 Increasing demand for healthcare services to bolster growth 182 9.3.3 UK 187 9.3.3.1 Aging population and rising patient pool to expedite growth 187 9.3.4 FRANCE 192 9.3.4.1 Favorable government support to boost market 192 9.3.5 ITALY 197 9.3.5.1 Universal eligibility for home care to favor growth 197 9.3.6 SPAIN 202 9.3.6.1 Upsurge in elderly population to accelerate growth 202 9.3.7 REST OF EUROPE 207 9.4 ASIA PACIFIC 212 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 213 9.4.2 JAPAN 219 9.4.2.1 High life expectancy and growing healthcare innovations to fuel market 219 9.4.3 CHINA 224 9.4.3.1 Increasing cases of diabetes and diabetic foot ulcers to favor growth 224 9.4.4 INDIA 229 9.4.4.1 Rising disposable income and focus on personalized care to spur growth 229 9.4.5 REST OF ASIA PACIFIC 234 9.5 LATIN AMERICA 239 9.5.1 RISING HEALTHCARE NEEDS TO AID GROWTH 239 9.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 240 9.6 MIDDLE EAST & AFRICA 245 9.6.1 GROWING INVESTMENTS IN HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET 245 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 246   9.7 GCC COUNTRIES 251 9.7.1 DIGITAL TRANSFORMATION AND EXPANDING PUBLIC-PRIVATE PARTNERSHIPS TO FUEL MARKET 251 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 252 10 COMPETITIVE LANDSCAPE 258 10.1 OVERVIEW 258 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 258 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 259 10.3 REVENUE ANALYSIS, 2022–2024 262 10.4 MARKET SHARE ANALYSIS, 2024 262 10.5 COMPANY VALUATION AND FINANCIAL METRICS 265 10.6 BRAND/PRODUCT COMPARISON 266 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 266 10.7.1 STARS 266 10.7.2 EMERGING LEADERS 267 10.7.3 PERVASIVE PLAYERS 267 10.7.4 PARTICIPANTS 267 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 268 10.7.5.1 Company footprint 268 10.7.5.2 Region footprint 269 10.7.5.3 Product & service footprint 270 10.7.5.4 Product footprint 270 10.7.5.5 End-user footprint 271 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 272 10.8.1 PROGRESSIVE COMPANIES 272 10.8.2 RESPONSIVE COMPANIES 272 10.8.3 DYNAMIC COMPANIES 272 10.8.4 STARTING BLOCKS 272 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 274 10.8.5.1 Detailed list of key startups/SMEs 274 10.8.5.2 Competitive benchmarking of key startups/SMEs 275 10.9 COMPETITIVE SCENARIO 275 10.9.1 PRODUCT LAUNCHES AND APPROVALS 275 10.9.2 DEALS 277 10.9.3 EXPANSIONS 279   11 COMPANY PROFILES 280 11.1 KEY PLAYERS 280 11.1.1 FRESENIUS MEDICAL CARE AG 280 11.1.1.1 Business overview 280 11.1.1.2 Products/Solutions/Services offered 281 11.1.1.3 Recent developments 282 11.1.1.3.1 Product launches and approvals 282 11.1.1.3.2 Deals 283 11.1.1.3.3 Expansions 283 11.1.1.4 MnM view 283 11.1.1.4.1 Key strengths 283 11.1.1.4.2 Strategic choices 284 11.1.1.4.3 Weaknesses and competitive threats 284 11.1.2 ABBOTT 285 11.1.2.1 Business overview 285 11.1.2.2 Products/Solutions/Services offered 287 11.1.2.3 Recent developments 288 11.1.2.3.1 Product launches and approvals 288 11.1.2.3.2 Deals 288 11.1.2.3.3 Expansions 289 11.1.2.4 MnM view 289 11.1.2.4.1 Key strengths 289 11.1.2.4.2 Strategic choices 289 11.1.2.4.3 Weaknesses and competitive threats 289 11.1.3 LINDE PLC 290 11.1.3.1 Business overview 290 11.1.3.2 Products/Solutions/Services offered 291 11.1.3.3 MnM view 292 11.1.3.3.1 Key strengths 292 11.1.3.3.2 Strategic choices 292 11.1.3.3.3 Weaknesses and competitive threats 292 11.1.4 F. HOFFMANN-LA ROCHE LTD 293 11.1.4.1 Business overview 293 11.1.4.2 Products/Solutions/Services offered 294 11.1.4.3 Recent developments 294 11.1.4.3.1 Product launches and approvals 294 11.1.4.4 MnM view 295 11.1.4.4.1 Key strengths 295 11.1.4.4.2 Strategic choices 295 11.1.4.4.3 Weaknesses and competitive threats 295   11.1.5 RESMED 296 11.1.5.1 Business overview 296 11.1.5.2 Products/Solutions/Services offered 297 11.1.5.3 Recent developments 298 11.1.5.3.1 Product launches and approvals 298 11.1.5.3.2 Deals 299 11.1.5.4 MnM view 299 11.1.5.4.1 Key strengths 299 11.1.5.4.2 Strategic choices 299 11.1.5.4.3 Weaknesses and competitive threats 299 11.1.6 KONINKLIJKE PHILIPS N.V. 300 11.1.6.1 Business overview 300 11.1.6.2 Products/Solutions/Services offered 301 11.1.6.3 Recent developments 303 11.1.6.3.1 Product launches and approvals 303 11.1.6.3.2 Deals 304 11.1.7 GE HEALTHCARE 305 11.1.7.1 Business overview 305 11.1.7.2 Products/Solutions/Services offered 306 11.1.7.3 Recent developments 308 11.1.7.3.1 Deals 308 11.1.8 A&D HOLON HOLDINGS COMPANY, LIMITED 309 11.1.8.1 Business overview 309 11.1.8.2 Products/Solutions/Services offered 310 11.1.9 CONVATEC GROUP PLC 312 11.1.9.1 Business overview 312 11.1.9.2 Products/Solutions/Services offered 313 11.1.9.3 Recent developments 314 11.1.9.3.1 Product launches and approvals 314 11.1.9.4 Recent developments 314 11.1.9.4.1 Expansions 315 11.1.10 AMEDISYS 316 11.1.10.1 Business overview 316 11.1.10.2 Products/solutions/services offered 317 11.1.10.3 Recent developments 318 11.1.10.3.1 Deals 318 11.1.11 OMRON HEALTHCARE CO., LTD. 320 11.1.11.1 Business overview 320 11.1.11.2 Products/Solutions/Services offered 322 11.1.11.3 Recent developments 324 11.1.11.3.1 Deals 324   11.2 OTHER PLAYERS 325 11.2.1 INVACARE CORPORATION 325 11.2.2 BAYADA HOME HEALTH CARE 326 11.2.3 DRIVE DEVILBISS HEALTHCARE 327 11.2.4 SUNRISE MEDICAL 328 11.2.5 ROMA MEDICAL 330 11.2.6 CAREMAX REHABILITATION EQUIPMENT CO., LTD. 332 11.2.7 VITALOGRAPH 333 11.2.8 ADVITA PFLEGEDIENST GMBH 334 11.2.9 THE RENAFAN GROUP 335 11.2.10 CONTEC MEDICAL SYSTEMS CO., LTD. 336 11.2.11 B. BRAUN SE 337 11.2.12 BAXTER 338 11.2.13 MEDLINE INDUSTRIES 339 11.2.14 ADVIN HEALTH CARE 340 12 APPENDIX 341 12.1 DISCUSSION GUIDE 341 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 346 12.3 CUSTOMIZATION OPTIONS 348 12.4 RELATED REPORTS 348 12.5 AUTHOR DETAILS 349

TABLE 1 HOME HEALTHCARE MARKET: INCLUSIONS AND EXCLUSIONS 30 TABLE 2 HOME HEALTHCARE MARKET: RISK ANALYSIS 42 TABLE 3 GERIATRIC POPULATION, 2022 VS. 2050 (MILLION) 52 TABLE 4 PRODUCT LAUNCHES BY KEY PLAYERS, 2022–2024 53 TABLE 5 AVERAGE SELLING PRICING TREND OF HOME HEALTHCARE PRODUCTS, BY TYPE, 2023–2025 (USD) 60 TABLE 6 AVERAGE SELLING PRICE TREND OF HOME HEALTHCARE PRODUCTS, BY KEY PLAYER, 2023–2025 (USD) 60 TABLE 7 AVERAGE SELLING PRICE TREND OF HOME HEALTHCARE PRODUCTS, BY REGION, 2023–2025 (USD) 61 TABLE 8 HOME HEALTHCARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM 64 TABLE 9 HOME HEALTHCARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024 69 TABLE 10 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION) 70 TABLE 11 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION) 70 TABLE 12 HOME HEALTHCARE MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 71 TABLE 13 US FDA: CLASSIFICATION OF MEDICAL DEVICES 72 TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73 TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73 TABLE 16 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES 75 TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 76 TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 23 HOME HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 81 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS (%) 83 TABLE 25 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS 83 TABLE 26 US ADJUSTED RECIPROCAL TARIFF RATES 87 TABLE 27 HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 91 TABLE 28 KEY THERAPEUTIC PRODUCTS OFFERED 92 TABLE 29 HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 92 TABLE 30 HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 93 TABLE 31 HOME HEALTHCARE MARKET FOR DIALYSIS EQUIPMENT, BY REGION, 2023–2030 (USD MILLION) 94 TABLE 32 HOME HEALTHCARE MARKET FOR WOUND CARE PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 95 TABLE 33 HOME HEALTHCARE MARKET FOR IV EQUIPMENT, BY REGION, 2023–2030 (USD MILLION) 96 TABLE 34 HOME HEALTHCARE MARKET FOR SLEEP APNEA THERAPEUTIC DEVICES, BY REGION, 2023–2030 (USD MILLION) 97 TABLE 35 HOME HEALTHCARE MARKET FOR INSULIN DELIVERY DEVICES, BY REGION, 2023–2030 (USD MILLION) 98 TABLE 36 HOME HEALTHCARE MARKET FOR OXYGEN DELIVERY SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 37 HOME HEALTHCARE MARKET FOR INHALERS, BY REGION, 2023–2030 (USD MILLION) 100 TABLE 38 HOME HEALTHCARE MARKET FOR NEBULIZERS, BY REGION, 2023–2030 (USD MILLION) 101 TABLE 39 HOME HEALTHCARE MARKET FOR VENTILATORS, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 40 HOME HEALTHCARE MARKET FOR OTHER THERAPEUTIC PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 41 KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED BY MAJOR COMPANIES 103 TABLE 42 HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 105 TABLE 43 HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2023–2030 (MILLION UNITS) 106 TABLE 44 HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 45 HOME HEALTHCARE MARKET FOR BLOOD GLUCOSE MONITORS, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 46 HOME HEALTHCARE MARKET FOR HEARING AIDS, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 47 HOME HEALTHCARE MARKET FOR ACTIVITY MONITORS & WRISTBANDS, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 48 HOME HEALTHCARE MARKET FOR ECG/EKG DEVICES, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 49 HOME HEALTHCARE MARKET FOR TEMPERATURE MONITORING DEVICES, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 50 HOME HEALTHCARE MARKET FOR HEART RATE MONITORS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 51 KEY INNOVATIONS IN PULSE OXIMETERS BY MAJOR COMPANIES 112 TABLE 52 HOME HEALTHCARE MARKET FOR PULSE OXIMETERS, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 53 HOME HEALTHCARE MARKET FOR OVULATION & PREGNANCY TEST KITS, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 54 HOME HEALTHCARE MARKET FOR BLOOD PRESSURE MONITORS, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 55 NUMBER OF PEOPLE LIVING WITH HIV VS. NEW HIV CASES, BY REGION, 2023 116 TABLE 56 HOME HEALTHCARE MARKET FOR HIV TEST KITS, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 57 HOME HEALTHCARE MARKET FOR FETAL MONITORING DEVICES, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 58 HOME HEALTHCARE MARKET FOR HOLTER & EVENT MONITORS, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 59 HOME HEALTHCARE MARKET FOR DRUG & ALCOHOL TEST KITS, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 60 HOME HEALTHCARE MARKET FOR COAGULATION MONITORING PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 61 HOME HEALTHCARE MARKET FOR PEAK FLOW METERS, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 62 HOME HEALTHCARE MARKET FOR COLON CANCER TEST KITS, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 63 HOME HEALTHCARE MARKET FOR EEG DEVICES, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 64 HOME HEALTHCARE MARKET FOR HOME SLEEP TESTING DEVICES, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 65 HOME HEALTHCARE MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 66 HOME HEALTHCARE MARKET FOR HOME HBA1C TEST KITS, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 67 KEY MOBILITY CARE PRODUCTS OFFERED BY MAJOR PLAYERS 127 TABLE 68 HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 128 TABLE 69 HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 70 HOME HEALTHCARE MARKET FOR WHEELCHAIRS, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 71 HOME HEALTHCARE MARKET FOR MOBILITY SCOOTERS, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 72 HOME HEALTHCARE MARKET FOR WALKERS & ROLLATORS, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 73 HOME HEALTHCARE MARKET FOR CRUTCHES, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 74 HOME HEALTHCARE MARKET FOR CANES, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 75 HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 76 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 77 HOME HEALTHCARE MARKET FOR SKILLED NURSING SERVICES, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 78 HOME HEALTHCARE MARKET FOR REHABILITATION THERAPY SERVICES, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 79 HOME HEALTHCARE MARKET FOR HOSPICE & PALLIATIVE CARE SERVICES, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 80 HOME HEALTHCARE MARKET FOR UNSKILLED SERVICES, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 81 HOME HEALTHCARE MARKET FOR RESPIRATORY THERAPY SERVICES, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 82 HOME HEALTHCARE MARKET FOR INFUSION THERAPY SERVICES, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 83 HOME HEALTHCARE MARKET FOR PREGNANCY CARE SERVICES, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 84 HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 147 TABLE 85 HOME HEALTHCARE INDICATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 86 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION) 149 TABLE 87 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 88 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 89 HOME HEALTHCARE MARKET FOR MOBILITY DISORDERS, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 90 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 91 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 92 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 93 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 94 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 95 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 96 HOME HEALTHCARE MARKET, BY REGION, 2023–2030 (USD MILLION) 159 TABLE 97 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 161 TABLE 98 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 99 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 162 TABLE 100 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 162 TABLE 101 NORTH AMERICA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 102 NORTH AMERICA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 103 NORTH AMERICA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 104 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 105 NORTH AMERICA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 106 US: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 167 TABLE 107 US: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 168 TABLE 108 US: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 109 US: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 110 US: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 111 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 112 US: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 113 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 172 TABLE 114 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 173 TABLE 115 CANADA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 116 CANADA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 117 CANADA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 118 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 119 CANADA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 120 EUROPE: KEY MACROECONOMIC INDICATORS 177 TABLE 121 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 122 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 178 TABLE 123 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 178 TABLE 124 EUROPE: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 125 EUROPE: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 126 EUROPE: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 127 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 128 EUROPE: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 129 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 183 TABLE 130 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 183 TABLE 131 GERMANY: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 132 GERMANY: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 133 GERMANY: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 134 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 135 GERMANY: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 136 UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 188 TABLE 137 UK: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 188 TABLE 138 UK: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 139 UK: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 140 UK: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 141 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 142 UK: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 143 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 193 TABLE 144 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 193 TABLE 145 FRANCE: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 146 FRANCE: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 147 FRANCE: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 148 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 149 FRANCE: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 150 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 198 TABLE 151 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 198 TABLE 152 ITALY: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 153 ITALY: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 154 ITALY: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 155 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 156 ITALY: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 157 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 203 TABLE 158 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 203 TABLE 159 SPAIN: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 160 SPAIN: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 161 SPAIN: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 162 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 163 SPAIN: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 164 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 208 TABLE 165 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 208 TABLE 166 REST OF EUROPE: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 167 REST OF EUROPE: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 168 REST OF EUROPE: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 169 REST OF EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 170 REST OF EUROPE: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 171 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 213 TABLE 172 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 173 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 215 TABLE 174 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 215 TABLE 175 ASIA PACIFIC: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 176 ASIA PACIFIC: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 177 ASIA PACIFIC: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 178 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 179 ASIA PACIFIC: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 180 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 220 TABLE 181 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 220 TABLE 182 JAPAN: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 183 JAPAN: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 184 JAPAN: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 185 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 186 JAPAN: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 187 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 225 TABLE 188 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 226 TABLE 189 CHINA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 190 CHINA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 191 CHINA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 192 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 193 CHINA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 194 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD BILLION) 230 TABLE 195 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 230 TABLE 196 INDIA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 197 INDIA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 198 INDIA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 199 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 200 INDIA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 201 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD BILLION) 235 TABLE 202 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 236 TABLE 203 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 204 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 205 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 206 REST OF ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 207 REST OF ASIA PACIFIC: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 208 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 240 TABLE 209 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD BILLION) 241 TABLE 210 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 241 TABLE 211 LATIN AMERICA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 212 LATIN AMERICA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 213 LATIN AMERICA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 214 LATIN AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 215 LATIN AMERICA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 216 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 247 TABLE 217 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD BILLION) 247 TABLE 218 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 247 TABLE 219 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 220 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 221 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 222 MIDDLE EAST & AFRICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 223 MIDDLE EAST & AFRICA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 224 GCC COUNTRIES: KEY MACROECONOMIC INDICATORS 253 TABLE 225 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD BILLION) 253 TABLE 226 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 253 TABLE 227 GCC COUNTRIES: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 228 GCC COUNTRIES: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 229 GCC COUNTRIES: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 230 GCC COUNTRIES: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 231 GCC COUNTRIES: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 232 HOME HEALTHCARE MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2022–JUNE 2025 259 TABLE 233 HOME HEALTHCARE MARKET: DEGREE OF COMPETITION, 2024 (%) 263 TABLE 234 HOME HEALTHCARE MARKET: REGION FOOTPRINT 269 TABLE 235 HOME HEALTHCARE MARKET: PRODUCT & SERVICE FOOTPRINT 270 TABLE 236 HOME HEALTHCARE MARKET: PRODUCT FOOTPRINT 270 TABLE 237 HOME HEALTHCARE MARKET: END-USER FOOTPRINT 271 TABLE 238 HOME HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 274 TABLE 239 HOME HEALTHCARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 275 TABLE 240 HOME HEALTHCARE MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025 276 TABLE 241 HOME HEALTHCARE MARKET: DEALS, JANUARY 2022–JUNE 2025 277 TABLE 242 HOME HEALTHCARE MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 279 TABLE 243 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW 280 TABLE 244 FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281 TABLE 245 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025 282 TABLE 246 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2022–JUNE 2025 283 TABLE 247 FRESENIUS MEDICAL CARE AG: EXPANSIONS, JANUARY 2022–JUNE 2025 283 TABLE 248 ABBOTT: COMPANY OVERVIEW 285 TABLE 249 ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 287 TABLE 250 ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025 288 TABLE 251 ABBOTT: DEALS, JANUARY 2022–JUNE 2025 288 TABLE 252 ABBOTT: EXPANSIONS, JANUARY 2022–JUNE 2025 289 TABLE 253 LINDE PLC: COMPANY OVERVIEW 290 TABLE 254 LINDE PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 291 TABLE 255 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW 293 TABLE 256 F. HOFFMAN-LA ROCHE LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 294 TABLE 257 F. HOFFMAN-LA ROCHE LTD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025 294 TABLE 258 RESMED: COMPANY OVERVIEW 296 TABLE 259 RESMED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 297 TABLE 260 RESMED: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025 298 TABLE 261 RESMED: DEALS, JANUARY 2022–JUNE 2025 299 TABLE 262 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 300 TABLE 263 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 301 TABLE 264 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025 303 TABLE 265 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JUNE 2025 304 TABLE 266 GE HEALTHCARE: COMPANY OVERVIEW 305 TABLE 267 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 306 TABLE 268 GE HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025 308 TABLE 269 A&D HOLON HOLDINGS COMPANY, LIMITED: COMPANY OVERVIEW 309 TABLE 270 A&D HOLON HOLDINGS COMPANY, LIMITED: PRODUCTS/SOLUTIONS/ SERVICES OFFERED 310 TABLE 271 CONVATEC GROUP PLC: COMPANY OVERVIEW 312 TABLE 272 CONVATEC GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 313 TABLE 273 CONVATEC GROUP PLC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025 314 TABLE 274 CONVATEC GROUP PLC: DEALS, JANUARY 2022–JUNE 2025 314 TABLE 275 CONVATEC GROUP PLC: EXPANSIONS, JANUARY 2022–JUNE 2025 315 TABLE 276 AMEDISYS: COMPANY OVERVIEW 316 TABLE 277 AMEDISYS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 317 TABLE 278 AMEDISYS: DEALS, JANUARY 2022–JUNE 2025 318 TABLE 279 OMRON HEALTHCARE CO., LTD.: COMPANY OVERVIEW 320 TABLE 280 OMRON HEALTHCARE CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 322 TABLE 281 OMRON HEALTHCARE CO., LTD.: DEALS, JANUARY 2022–JUNE 2025 324 TABLE 282 INVACARE CORPORATION: COMPANY OVERVIEW 325 TABLE 283 BAYADA HOME HEALTH CARE: COMPANY OVERVIEW 326 TABLE 284 DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW 327 TABLE 285 SUNRISE MEDICAL: COMPANY OVERVIEW 328 TABLE 286 ROMA MEDICAL: COMPANY OVERVIEW 330 TABLE 287 CAREMAX REHABILITATION EQUIPMENT CO., LTD.: COMPANY OVERVIEW 332 TABLE 288 VITALOGRAPH: COMPANY OVERVIEW 333 TABLE 289 ADVITA PFLEGEDIENST GMBH: COMPANY OVERVIEW 334 TABLE 290 THE RENAFAN GROUP: COMPANY OVERVIEW 335 TABLE 291 CONTEC MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW 336 TABLE 292 B. BRAUN SE: COMPANY OVERVIEW 337 TABLE 293 BAXTER: COMPANY OVERVIEW 338 TABLE 294 MEDLINE INDUSTRIES: COMPANY OVERVIEW 339 TABLE 295 ADVIN HEALTH CARE: COMPANY OVERVIEW 340 FIGURE 1 HOME HEALTHCARE MARKET SEGMENTATION AND REGIONAL SCOPE 29 FIGURE 2 HOME HEALTHCARE MARKET: RESEARCH DESIGN 32 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36 FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 37 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38 FIGURE 6 HOME HEALTHCARE MARKET: TOP-DOWN APPROACH 39 FIGURE 7 DATA TRIANGULATION METHODOLOGY 40 FIGURE 8 HOME HEALTHCARE MARKET: PARAMETRIC ASSUMPTIONS 41 FIGURE 9 HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD BILLION) 43 FIGURE 10 HOME HEALTHCARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD BILLION) 44 FIGURE 11 HOME HEALTHCARE MARKET, BY SERVICE, 2025 VS. 2030 (USD BILLION) 44 FIGURE 12 HOME HEALTHCARE MARKET, BY INDICATION, 2025 VS. 2030 (USD BILLION) 45 FIGURE 13 HOME HEALTHCARE MARKET: GEOGRAPHICAL SNAPSHOT 46 FIGURE 14 GROWING ELDERLY POPULATION AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 47 FIGURE 15 JAPAN TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 48 FIGURE 16 ASIA PACIFIC TO LEAD MARKET DURING FORECAST PERIOD 49 FIGURE 17 DEVELOPED MARKETS TO HAVE LARGER SHARE DURING FORECAST PERIOD 50 FIGURE 18 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 FIGURE 19 HOME HEALTHCARE MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 59 FIGURE 20 HOME HEALTHCARE MARKET: VALUE CHAIN ANALYSIS 62 FIGURE 21 HOME HEALTHCARE MARKET: SUPPLY CHAIN ANALYSIS 63 FIGURE 22 HOME HEALTHCARE MARKET: ECOSYSTEM ANALYSIS 64 FIGURE 23 HOME HEALTHCARE MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2024 65 FIGURE 24 HOME HEALTHCARE MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024 68 FIGURE 25 CANADA: APPROVAL PROCESS FOR MEDICAL DEVICES 74 FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 75 FIGURE 27 HOME HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 80 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS 82 FIGURE 29 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS 83 FIGURE 30 AI USE CASES 85 FIGURE 31 ADJACENT MARKETS FOR HOME HEALTHCARE MARKET 86 FIGURE 32 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT 160 FIGURE 33 ASIA PACIFIC: HOME HEALTHCARE MARKET SNAPSHOT 214 FIGURE 34 HOME HEALTHCARE MARKET: REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS, 2022–2024 (USD MILLION) 262 FIGURE 35 HOME HEALTHCARE MARKET SHARE ANALYSIS, 2024 (%) 263 FIGURE 36 EV/EBITDA OF KEY VENDORS, 2025 265 FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 265 FIGURE 38 HOME HEALTHCARE MARKET: BRAND/PRODUCT COMPARISON 266 FIGURE 39 HOME HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 267 FIGURE 40 HOME HEALTHCARE MARKET: COMPANY FOOTPRINT 268 FIGURE 41 HOME HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 273 FIGURE 42 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT (2024) 281 FIGURE 43 ABBOTT: COMPANY SNAPSHOT (2024) 286 FIGURE 44 LINDE PLC: COMPANY SNAPSHOT (2024) 291 FIGURE 45 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2024) 293 FIGURE 46 RESMED: COMPANY SNAPSHOT (2024) 297 FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 301 FIGURE 48 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 306 FIGURE 49 A&D HOLON HOLDINGS COMPANY, LIMITED: COMPANY SNAPSHOT (2024) 310 FIGURE 50 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024) 313 FIGURE 51 AMEDISYS: COMPANY SNAPSHOT (2024) 316 FIGURE 52 OMRON HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2024) 321